세계의 발진 시장 보고서(2025년)

Exanthema is a term used to describe a widespread skin rash or eruption, often resulting from a viral infection such as measles, rubella, or chickenpox (varicella). It plays a crucial role in diagnosing and identifying viral illnesses, as the rash's specific characteristics can help healthcare professionals determine the cause of the infection and decide on the most suitable treatment and management approaches.

The primary types of exanthema include bacterial, viral, and other forms. Bacterial exanthema is caused by infections from bacteria such as Streptococcus or Staphylococcus, leading to skin rashes. Treatment options involve topical medications, systemic therapies, and supportive care, with diagnostic methods including clinical examination, laboratory tests, and imaging techniques. Common conditions associated with exanthema include rubeola, rubella, erythema infectiosum, and roseola infantum. These diagnostic and treatment approaches are used by various healthcare providers, including hospitals, homecare services, and specialty centers.

The exanthema market research report is one of a series of new reports from The Business Research Company that provides exanthema market statistics, including the exanthema industry global market size, regional shares, competitors with the exanthema market share, detailed exanthema market segments, market trends, and opportunities, and any further data you may need to thrive in the exanthema industry. This exanthema market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The exanthema market size has grown steadily in recent years. It will grow from $2.18 billion in 2024 to $2.28 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth during the historical period can be attributed to factors such as higher healthcare spending, increased awareness about vaccination, rising disposable incomes, greater understanding of skin disorders, and a stronger focus on early detection.

The exanthema market size is expected to see steady growth in the next few years. It will grow to $2.71 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth during the forecast period can be attributed to increased investments in research and development, a higher prevalence of viral and bacterial infections, a growing emphasis on telemedicine, expanding government initiatives, and a rising demand for oral medications. Key trends during this period include advancements in treatment approaches, innovations in diagnostic techniques, technological progress, breakthroughs in medical research and technology, and the development of assistive technologies.

The increasing prevalence of viral infections is expected to drive the growth of the exanthema market in the coming years. Viral infections are illnesses caused by viruses that invade and replicate within the body's cells, resulting in various symptoms and diseases. Factors such as global travel, urbanization, climate change, and weakened immunity in populations are contributing to the rising frequency of viral infections. As more cases present with skin rashes, there is a growing need for effective exanthema treatments. Exanthema, which serves as a visible immune response to viral infections, plays a role in expelling pathogens, signaling immune activation, and assisting in diagnosis by showing the body's fight against the virus. For example, according to the Centers for Disease Control and Prevention (CDC), between 2022 and 2024, the percentage of individuals with IgM antibodies, which indicate a recent Parvovirus B19 infection, remained below 3%, but surged to 10% by June 2024. The most significant rise occurred among children aged 5-9, where the prevalence increased from 15% to 40% during this period. As a result, the increasing prevalence of viral infections is driving the growth of the exanthema market.

Companies operating in the exanthema market are making strides in developing new therapeutics, including intramuscular (IM) administration of vaccines and antiviral treatments. This method, which involves delivering vaccines or medications directly into the muscle tissue via a syringe and needle, ensures quick absorption into the bloodstream. By leveraging the rich blood supply in the muscles, the IM administration prompts a therapeutic or immune response, improving the efficacy of the treatment. For example, in March 2023, Merck & Co. Inc. announced that the FDA had approved the IM administration route for its MMRV vaccines-M-M-R II, VARIVAX, and ProQuad. This method offers greater stability and efficacy for these live-virus vaccines compared to other administration methods, making it a key step in enhancing public health efforts to prevent severe viral infections.

In September 2024, Organon, a US-based healthcare company, acquired Dermavant Sciences Ltd. for $1.2 billion. Dermavant Sciences is a clinical-stage biopharmaceutical company that focuses on developing innovative therapeutics in immunodermatology. This acquisition strengthens Organon's position in the dermatology field and aligns with its objectives to expand its portfolio with cutting-edge therapies.

Major players in the exanthema market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi SA, Abbott Laboratories, GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Company Limited, Amgen Inc., Daiichi Sankyo Company Limited, Biological E. Limited, Zydus Lifesciences Limited, Bio Farma, Meridian Bioscience Inc., West-Ward Pharmaceutical Corp., Trinity Biotech plc, Biosynth Srl, Creative Diagnostics, Taj Pharmaceuticals Limited, TestLine Clinical Diagnostics s.r.o., The Native Antigen Co. Ltd., and QED Bioscience Inc.

North America was the largest region in the exanthema market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in exanthema report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the exanthema market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The exanthema market consists of revenues earned by entities by providing services such as antiviral treatment services, vaccination services, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The exanthema market also includes sales of topical corticosteroids, antihistamines, immunosuppressants, antiviral medications, and moisturizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exanthema Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exanthema market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exanthema ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The exanthema market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Types: Bacterial; Viral; Other Types
• 2) By Treatment: Topical Treatments; Systemic Treatments; Supportive Care
• 3) By Diagnosis Method: Clinical Examination; Laboratory Tests; Imaging Techniques
• 4) By Application: Rubeola; Rubella; Erythema Infectiosum; Roseola Infantum
• 5) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users
• Subsegments:
• 1) By Bacterial Exanthema: Scarlet Fever; Meningococcemia; Staphylococcal Scalded Skin Syndrome (SSSS); Lyme Disease; Tuberculosis-Associated Exanthema
• 2) By Viral Exanthema: Measles (Rubeola); Rubella (German Measles); Varicella (Chickenpox); Roseola (Exanthem Subitum); Hand, Foot, and Mouth Disease; Parvovirus B19 (Erythema Infectiosum / Fifth Disease); Dengue Fever Rash; Zika Virus Rash
• 3) By Other Types of Exanthema: Drug-Induced Exanthema (Hypersensitivity Reactions); Autoimmune-Related Exanthema (Lupus, Kawasaki Disease); Allergic Dermatitis-Related Exanthema; Fungal Infections Leading to Exanthema; Environmental and Toxin-Induced Exanthema
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Sanofi SA; Abbott Laboratories; GlaxoSmithKline plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Exanthema Market Characteristics

3. Exanthema Market Trends And Strategies

4. Exanthema Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Exanthema Growth Analysis And Strategic Analysis Framework

• 5.1. Global Exanthema PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Exanthema Market Growth Rate Analysis
• 5.4. Global Exanthema Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Exanthema Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Exanthema Total Addressable Market (TAM)

6. Exanthema Market Segmentation

• 6.1. Global Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial
• Viral
• Other Types
• 6.2. Global Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Treatments
• Systemic Treatments
• Supportive Care
• 6.3. Global Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Examination
• Laboratory Tests
• Imaging Techniques
• 6.4. Global Exanthema Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rubeola
• Rubella
• Erythema Infectiosum
• Roseola Infantum
• 6.5. Global Exanthema Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Speciality Centres
• Other End-Users
• 6.6. Global Exanthema Market, Sub-Segmentation Of Bacterial Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Scarlet Fever
• Meningococcemia
• Staphylococcal Scalded Skin Syndrome (SSSS)
• Lyme Disease
• Tuberculosis-Associated Exanthema
• 6.7. Global Exanthema Market, Sub-Segmentation Of Viral Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Measles (Rubeola)
• Rubella (German Measles)
• Varicella (Chickenpox)
• Roseola (Exanthem Subitum)
• Hand, Foot, and Mouth Disease
• Parvovirus B19 (Erythema Infectiosum / Fifth Disease)
• Dengue Fever Rash
• Zika Virus Rash
• 6.8. Global Exanthema Market, Sub-Segmentation Of Other Types of Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Induced Exanthema (Hypersensitivity Reactions)
• Autoimmune-Related Exanthema (Lupus, Kawasaki Disease)
• Allergic Dermatitis-Related Exanthema
• Fungal Infections Leading to Exanthema
• Environmental and Toxin-Induced Exanthema

7. Exanthema Market Regional And Country Analysis

• 7.1. Global Exanthema Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Exanthema Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Exanthema Market

• 8.1. Asia-Pacific Exanthema Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Exanthema Market

• 9.1. China Exanthema Market Overview
• 9.2. China Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Exanthema Market

• 10.1. India Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Exanthema Market

• 11.1. Japan Exanthema Market Overview
• 11.2. Japan Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Exanthema Market

• 12.1. Australia Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Exanthema Market

• 13.1. Indonesia Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Exanthema Market

• 14.1. South Korea Exanthema Market Overview
• 14.2. South Korea Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Exanthema Market

• 15.1. Western Europe Exanthema Market Overview
• 15.2. Western Europe Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Exanthema Market

• 16.1. UK Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Exanthema Market

• 17.1. Germany Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Exanthema Market

• 18.1. France Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Exanthema Market

• 19.1. Italy Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Exanthema Market

• 20.1. Spain Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Exanthema Market

• 21.1. Eastern Europe Exanthema Market Overview
• 21.2. Eastern Europe Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Exanthema Market

• 22.1. Russia Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Exanthema Market

• 23.1. North America Exanthema Market Overview
• 23.2. North America Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Exanthema Market

• 24.1. USA Exanthema Market Overview
• 24.2. USA Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Exanthema Market

• 25.1. Canada Exanthema Market Overview
• 25.2. Canada Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Exanthema Market

• 26.1. South America Exanthema Market Overview
• 26.2. South America Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Exanthema Market

• 27.1. Brazil Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Exanthema Market

• 28.1. Middle East Exanthema Market Overview
• 28.2. Middle East Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Exanthema Market

• 29.1. Africa Exanthema Market Overview
• 29.2. Africa Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Exanthema Market Competitive Landscape And Company Profiles

• 30.1. Exanthema Market Competitive Landscape
• 30.2. Exanthema Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Exanthema Market Other Major And Innovative Companies

• 31.1. Serum Institute of India Pvt. Ltd.
• 31.2. Takeda Pharmaceutical Company Limited
• 31.3. Amgen Inc.
• 31.4. Daiichi Sankyo Company Limited
• 31.5. Biological E. Limited
• 31.6. Zydus Lifesciences Limited
• 31.7. Bio Farma
• 31.8. Meridian Bioscience Inc.
• 31.9. West-Ward Pharmaceutical Corp.
• 31.10. Trinity Biotech plc
• 31.11. Biosynth Srl
• 31.12. Creative Diagnostics
• 31.13. Taj Pharmaceuticals Limited
• 31.14. TestLine Clinical Diagnostics s.r.o.
• 31.15. The Native Antigen Co. Ltd.

32. Global Exanthema Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Exanthema Market

34. Recent Developments In The Exanthema Market

35. Exanthema Market High Potential Countries, Segments and Strategies

• 35.1 Exanthema Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Exanthema Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Exanthema Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer